These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32647705)

  • 1. A new role for IDH1 in the control of ovarian cancer cells metabolism and senescence.
    Sonego M; Baldassarre G
    Ann Transl Med; 2020 Jun; 8(12):780. PubMed ID: 32647705
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting IDH1 as a Prosenescent Therapy in High-grade Serous Ovarian Cancer.
    Dahl ES; Buj R; Leon KE; Newell JM; Imamura Y; Bitler BG; Snyder NW; Aird KM
    Mol Cancer Res; 2019 Aug; 17(8):1710-1720. PubMed ID: 31110157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of IDH1 by chronic unpredictable stress suppresses proliferation and accelerates senescence of granulosa cells through ROS activated MAPK signaling pathways.
    Sun J; Guo Y; Fan Y; Wang Q; Zhang Q; Lai D
    Free Radic Biol Med; 2021 Jun; 169():122-136. PubMed ID: 33865962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoallelic IDH1 R132H Mutation Mediates Glioma Cell Response to Anticancer Therapies via Induction of Senescence.
    Zhan D; Ma D; Wei S; Lal B; Fu Y; Eberhart C; Laterra J; Ying M; Li Y; Meeker A; Lopez-Bertoni H; Xia S
    Mol Cancer Res; 2021 Nov; 19(11):1878-1888. PubMed ID: 34348994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous in vitro senescence of glioma cells confirmed by an antibody against IDH1R132H.
    Stoczynska-Fidelus E; Och W; Rieske P; Bienkowski M; Banaszczyk M; Winiecka-Klimek M; Zieba J; Janik K; Rosiak K; Treda C; Stawski R; Radomiak-Zaluska A; Piaskowski S
    Anticancer Res; 2014 Jun; 34(6):2859-67. PubMed ID: 24922649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aurora-A/SOX8/FOXK1 signaling axis promotes chemoresistance via suppression of cell senescence and induction of glucose metabolism in ovarian cancer organoids and cells.
    Sun H; Wang H; Wang X; Aoki Y; Wang X; Yang Y; Cheng X; Wang Z; Wang X
    Theranostics; 2020; 10(15):6928-6945. PubMed ID: 32550913
    [No Abstract]   [Full Text] [Related]  

  • 7. IDH1, lipid metabolism and cancer: Shedding new light on old ideas.
    Bogdanovic E
    Biochim Biophys Acta; 2015 Sep; 1850(9):1781-5. PubMed ID: 25960387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Where does cellular senescence belong in the pathophysiology of ovarian cancer?
    Książek K
    Semin Cancer Biol; 2022 Jun; 81():14-23. PubMed ID: 33290845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-associated isocitrate dehydrogenase 1 (IDH1) R132H mutation and d-2-hydroxyglutarate stimulate glutamine metabolism under hypoxia.
    Reitman ZJ; Duncan CG; Poteet E; Winters A; Yan LJ; Gooden DM; Spasojevic I; Boros LG; Yang SH; Yan H
    J Biol Chem; 2014 Aug; 289(34):23318-28. PubMed ID: 24986863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular Senescence in the Treatment of Ovarian Cancer.
    Wang Z; Liu H; Xu C
    Int J Gynecol Cancer; 2018 Jun; 28(5):895-902. PubMed ID: 29688903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olaparib induced senescence under P16 or P53 dependent manner in ovarian cancer.
    Wang Z; Gao J; Zhou J; Liu H; Xu C
    J Gynecol Oncol; 2019 Mar; 30(2):e26. PubMed ID: 30740957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosiglitazone ameliorates senescence and promotes apoptosis in ovarian cancer induced by olaparib.
    Wang Z; Gao J; Ohno Y; Liu H; Xu C
    Cancer Chemother Pharmacol; 2020 Feb; 85(2):273-284. PubMed ID: 31907647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary high-grade serous ovarian cancer cells are sensitive to senescence induced by carboplatin and paclitaxel in vitro.
    Uruski P; Sepetowska A; Konieczna C; Pakuła M; Wyrwa M; Tussupkaliyev A; Tykarski A; Mikuła-Pietrasik J; Książek K
    Cell Mol Biol Lett; 2021 Oct; 26(1):44. PubMed ID: 34674640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress contributes to hepatocyte growth factor-dependent pro-senescence activity of ovarian cancer cells.
    Mikuła-Pietrasik J; Uruski P; Pakuła M; Maksin K; Szubert S; Woźniak A; Naumowicz E; Szpurek D; Tykarski A; Książek K
    Free Radic Biol Med; 2017 Sep; 110():270-279. PubMed ID: 28652056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleus accumbens-1/GADD45GIP1 axis mediates cisplatin resistance through cellular senescence in ovarian cancer.
    Nakayama K; Rahman M; Rahman MT; Nakamura K; Sato E; Katagiri H; Ishibashi T; Ishikawa M; Iida K; Razia S; Ishikawa N; Kyo S
    Oncol Lett; 2017 Jun; 13(6):4713-4719. PubMed ID: 28599472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-oncogenic PTEN induces ovarian cancer cell senescence by targeting P21.
    Ke X; Li L; Li J; Zheng M; Liu P
    Cell Biol Int; 2022 Jan; 46(1):118-128. PubMed ID: 34643308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant IDH1 Differently Affects Redox State and Metabolism in Glial Cells of Normal and Tumor Origin.
    Biedermann J; Preussler M; Conde M; Peitzsch M; Richter S; Wiedemuth R; Abou-El-Ardat K; Krüger A; Meinhardt M; Schackert G; Leenders WP; Herold-Mende C; Niclou SP; Bjerkvig R; Eisenhofer G; Temme A; Seifert M; Kunz-Schughart LA; Schröck E; Klink B
    Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31888244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IDH1 mutations alter citric acid cycle metabolism and increase dependence on oxidative mitochondrial metabolism.
    Grassian AR; Parker SJ; Davidson SM; Divakaruni AS; Green CR; Zhang X; Slocum KL; Pu M; Lin F; Vickers C; Joud-Caldwell C; Chung F; Yin H; Handly ED; Straub C; Growney JD; Vander Heiden MG; Murphy AN; Pagliarini R; Metallo CM
    Cancer Res; 2014 Jun; 74(12):3317-31. PubMed ID: 24755473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomal IDH1 increases the resistance of colorectal cancer cells to 5-Fluorouracil.
    Yang H; Xie S; Liang B; Tang Q; Liu H; Wang D; Huang G
    J Cancer; 2021; 12(16):4862-4872. PubMed ID: 34234856
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Xu C; Ooi WF; Qamra A; Tan J; Chua BY; Ho SWT; Das K; Adam Isa ZF; Li Z; Yao X; Yan T; Xing M; Huang KK; Lin JS; Nandi T; Tay ST; Lee MH; Tan ALK; Ong X; Ashktorab H; Smoot D; Li S; Ng SC; Teh BT; Tan P
    Gut; 2020 Feb; 69(2):231-242. PubMed ID: 31068366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.